MAIA Biotechnology, Inc.
MAIA
$1.32
$0.021.15%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 44.67% | 39.93% | 23.10% | -6.75% | -13.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.93% | 43.12% | 36.15% | 3.60% | -7.59% |
| Operating Income | -39.93% | -43.12% | -36.15% | -3.60% | 7.59% |
| Income Before Tax | -23.06% | 3.69% | 13.88% | 42.41% | 16.94% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.06% | 3.69% | 13.88% | 42.41% | 16.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.06% | 3.69% | 13.88% | 42.41% | 16.94% |
| EBIT | -39.93% | -43.12% | -36.15% | -3.60% | 7.59% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 16.69% | 36.75% | 45.50% | 63.14% | 47.76% |
| Normalized Basic EPS | 16.70% | 36.78% | 45.50% | 63.14% | 47.76% |
| EPS Diluted | 16.69% | 36.75% | 45.50% | 63.14% | 47.76% |
| Normalized Diluted EPS | 16.70% | 36.78% | 45.50% | 63.14% | 47.76% |
| Average Basic Shares Outstanding | 47.63% | 44.68% | 46.80% | 55.06% | 65.71% |
| Average Diluted Shares Outstanding | 47.63% | 44.68% | 46.80% | 55.06% | 65.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |